Muscle-invasive Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Muscle-invasive Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 trial update evaluating TAR-200 in combination with cetrelimab or cetrelimab alone in muscle-invasive urothelial carcinoma of the bl…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the combination of pembrolizumab and sacituzumab govitecan for high-risk, localized muscle-invasi…